+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pharmaceutical Packaging Market - Global Outlook & Forecast 2022-2027

  • PDF Icon

    Report

  • 335 Pages
  • December 2022
  • Region: Global
  • Arizton
  • ID: 5699645
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The global pharmaceutical packaging market is expected to grow at a CAGR of 4.65% during 2021-2027. The demand for advanced and innovative solutions, such as self-administered drug delivery devices, is rising in high-income countries, bringing lucrative opportunities for the pharmaceutical packaging market. In addition, diseases have increased in recent years, including various types of flu, the COVID-19 pandemic, monkeypox, and more. Rising healthcare expenses and growing consumer awareness regarding healthier lifestyles drive the industry.

The growing chronic disease prevalence, growth in the biologics market, and technological advancements are anticipated to propel the market. However, fluctuations in raw material prices, emerging markets such as newly developed drugs, and lack of compliance with regulatory standards hamper the market's growth.

Driving Factors In The Global Pharmaceutical Packaging Market

  • Rising pharmaceutical industry across the globe
  • A surge in demand for flexible packaging
  • Rising demand for biological products and emerging treatments such as cell and gene therapies
  • Aging Demographics of Industrialized Countries

Active Mergers And Acquisitions Playing A Key Role In Smooth Functioning For The Growth of The Global Pharmaceutical Packaging Market

a) In February 2018, Berry Global acquired Clopay Plastic Products Company for a purchase price of USD 475 million.
b) Berry Global completed the acquisition of RPC Group in July 2019. RPC Group is one of the global leaders in plastics conversion for packaging and non-packaging markets.
c) On June 11, 2019, Amcor acquired Bemis Company, a global manufacturer of flexible packaging products. Its flexible segment develops and supplies flexible packaging globally. In FY2021, the Flexible segment accounted for approximately 78% of Amcor’s net sales.
d) In November 2021, Gerresheimer acquired the IP of a new generation cartridge-based autoinjector suitable for small and large molecules, enhancing its broad portfolio, medical devices, and primary packaging from Midas Pharma. Midas Pharma is a Germany-based pharmaceutical company.
e) In 2018, Gerresheimer acquired Sensile Medical, a drug delivery technology company, and thus the company extended its business model in the OEM for drug delivery platforms for pharmaceutical and biopharmaceutical customers.

Increasing Virtual Consultations Is Anticipating The Growth Of Aluminium-Based Drug Packaging

High-income countries from North America and Europe are witnessing an increased adoption of virtual visits and e-prescriptions, leading to a large dependency on the home delivery of medicines. The home delivery of goods is one of the significant challenges for pharmaceutical packaging companies as the customers are not aware of the proper disposal of packaged products and materials, leading to a substantial environmental impact. Due to this concern, aluminum packaging is one of the improved solutions to overcome this issue.

INDUSTRY’S ONGOING TRENDS

Eco-Friendly Packaging

Around 85% of the waste produced by healthcare operations, including pharmaceutical and medical equipment packaging, is non-hazardous and, therefore, exhibits the potential to be replaced by other eco-friendly and reusable alternatives, enabling significant cost savings. Many pharma companies are shifting to sustainable packaging that uses recyclable materials and biodegradable plastics. Sustainable pharmaceutical packaging is expected to grow during the forecast period. PET (polyethylene terephthalate) is a recyclable plastic material. It is a very versatile material for the manufacturing of pharmaceutical products packaging. It has a good carbon dioxide (CO2), oxygen, and moisture barrier, allowing it to store liquids and solids as fresh as possible. Europe is expected to lead the growth in the biodegradable pharmaceutical packaging market. In Europe, the key players in the global biodegradable pharmaceutical packaging market include Gerresheimer, Berry Global, International Paper, and Amcor.

Introduction Of Anti-Counterfeiting Features

A counterfeit pharmaceutical product is deliberately and fraudulently mislabelled concerning identity. Counterfeit pharmaceutical products may include products with correct ingredients, wrong ingredients, without active ingredients, wrong ingredients with the inaccurate quantity of an active ingredient, or with fake packaging. The global pharmaceutical packaging market has witnessed a major challenge with the growing incidences of counterfeit products. As a result, many manufacturers in recent years have introduced several anti-counterfeiting features to fight the distribution of counterfeit pharmaceutical products. These anti-counterfeiting features include using thermochromic inks for labeling, holograms, QR code, RFID labels, and many more. Some innovations include child-resistant, senior-friendly & high barrier, unit-dose, multi-dose, and specialty film packaging.

IMPACT OF COVID-19
  • COVID-19 has shown adverse effects on the global healthcare industry and has thus contributed to hindering the growth of the pharmaceutical packaging market. The COVID-19 impact on the pharmaceutical sector included changes in demand, regulation adjustments, R&D process changes, and supply chain restructuring. In addition, trends such as industry slow-down, delays in approvals, modifying clinical trial methods, self-sufficiency in the pharmaceutical product supply chain, and variations in consumption of health & nutritional products are expected to be some of the long-term impacts of the COVID-19 pandemic on the pharmaceutical industry globally.
  • During the pandemic, pharma packaging companies witnessed stable revenue growth in 2020. Major pharmaceutical packaging companies increased their production capacity to support the increased demand for pre-filled syringes, blister packs, ampoules/vials, bags, cartridges, containers, and bottles. This was mainly due to a surge in demand for COVID-19-related medications and vaccines. Moreover, pharmaceutical packaging for biologics, sterile packaging, smart packaging, patient focus packaging, cleanroom expansion, and others are anticipated to drive the global pharmaceutical packaging market in the long term.

SEGMENTATION ANALYSIS

INSIGHTS BY TYPE SEGMENTATION

  • Primary pharmaceutical packaging segmentation accounted for the largest market share of 70.20% in 2021, owing to the growing demand for blister packs, bottles, vials, ampoules, pouches, sachets, and bags. The blister packs account for a significant revenue share of 35.23% in 2021 in the global pharmaceutical packaging market due to the high demand for prescription and non-prescription medications/drugs, among which the demand for generic drugs is the highest among LMIC. Although the pharmaceutical sector accounts for the major share of the global market, a consistent surge in blister packaging demand contributes to its cost-effectiveness. The evolution from simple bulk packaging materials toward ready-to-sterilize (RTS) primary packaging components and systems is the dominant trend in the primary packaging segment of the market
  • Innovations in secondary pharmaceutical packaging include developing child-resistant (CR) cartons, tamper-evident (TE) cartons, and cold-chain packaging. The secondary packaging segment accounted for 20.30% of the global pharmaceutical packaging market share.
  • Tertiary packaging is used for the safe handling and smooth transportation of products. Examples of tertiary packaging include plastic bags, shrink wraps, and cardboard boxes. The increasing trend of e-pharmacy will likely further the adoption of tertiary packaging in the pharmaceutical packaging market. It is expected to grow with a CAGR of 3.96% during the forecast period.

Segmentation by Type

  • Primary
  • Blister Packs
  • Bottles
  • Vials
  • Ampoules
  • Others
  • Secondary
  • Tertiary

INSIGHTS FROM MATERIAL SEGMENTATION

  • Paper materials accounted for the highest revenue share of 39.36% in 2021 in the global pharmaceutical packaging market due to their increasing demand in secondary and tertiary packaging, low cost, and increasing focus on recyclable and eco-friendly materials. Demand for paper-based packaging, both corrugated and folding cartons, has been rising across Europe during the last few years owing to its largest pharmaceutical market and the largest exporter of pharmaceuticals. WestRock Company is one of the leading manufacturers of paper-based packaging.
  • Plastics held the third largest share in 2021 in the pharmaceutical packaging market by material segmentation. It is expected to grow at the highest CAGR of 4.94% from 2022-2027, powered due its growing demand in all three packaging types. In addition, plastics are widely used in packaging because of their versatility, flexibility, and cost-effectiveness. However, due to its non-decomposable properties and its ban for use because of its environmental issues as it produces a high quantity of greenhouse gases has banned its use in several countries. As a result, recyclable plastics are in high demand. The most widely used-recyclable plastics in pharmaceutical packaging include PET, HDPE, and PP, among which PET is the most commonly recycled plastic worldwide, followed by HDPE. Several governments and companies are developing initiatives to use recycled plastics as packaging material for pharmaceutical medicines and supplies.

Segmentation by Material

  • Paper
  • Glass
  • Plastic
  • Others

INSIGHTS FROM END-USER SEGMENTATION

Pharmaceutical companies account for the highest market share of 48.18% in the global pharmaceutical packaging market by end-user segment. It is expected to grow at the highest CAGR of 5.10% during the forecast period. The highest revenue share of pharma companies is because pharmaceutical companies are the primary source for the pharmaceutical packaging market. As the demand for pharmaceuticals continues to grow, the need for packaging has also increased significantly.

Segmentation by End-User

  • Pharmaceutical Companies
  • CMO/ CDMO
  • Plastic

GEOGRAPHICAL ANALYSIS

North America accounts for 36% of the global pharmaceutical packaging market share. The growing pharmaceutical sales in North America are the major driving factor for the pharmaceutical packaging market in the region. North America, in particular the US, will continue to be the largest pharma packaging market long term due to the advanced drug-producing sector. The US market is expected to maintain moderate growth due to the increasing aging population, robust innovations, and increasing consumer demand for sophisticated packaging.

Emerging markets such as Brazil, China, and India are anticipated to grow at the fastest rate, which can be attributed to their large population and demographic factors such as a growing young population and longer life expectancy. APAC is estimated to show the highest growth of 5.01% during the forecast period. The pharmaceutical industry is booming, especially in developing countries such as China, India, and Brazil, as well as in developed countries such as the US, UK, and Germany. According to the India Brand Equity Foundation (IBEF), India is the largest provider of generic drugs globally. At the same time, the Indian pharmaceutical sector supplies around 50% of the global demand for several vaccines, 40% demand for generic drugs in the US, and 25% of all tablets in the UK.

Segmentation by Geography

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • Italy
  • Spain
  • France
  • UK
  • APAC
  • Japan
  • China
  • South Korea
  • India
  • Australia
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • South Africa

VENDORS LANDSCAPE

The global pharmaceutical packaging market is highly dynamic and competitive, with several international, regional, and local vendors offering a diverse and comprehensive range of pharmaceutical packaging products with wide applications. The key players in the industry are Berry Global, Amcor, Gerresheimer, WestRock, and AptarGroup.The industry also has the presence of prominent players, some of which include ACG, Airnov, Borosil, CCL Industries, and Drug Plastics Group.

Key Vendors

  • Amcor
  • Aptar Group
  • Berry Global
  • Gerresheimer
  • WestRock

Other Prominent Vendors

  • ACG
  • Airnov
  • AVI Global Plast
  • BD
  • Bilcare
  • Borosil
  • CCL Industries
  • Coesia
  • Drug Plastics Group
  • DWK Life Sciences
  • LOG
  • Meghmani Group
  • Neelam Global
  • Nolato
  • Nemera
  • PolyCine
  • RENOLIT
  • Schur Flexibles Holding
  • Specialty Polyfilms
  • SGD Pharma
  • SCHOTT
  • Sippex IV bags
  • SUPER OLEFINS
  • West Pharmaceutical Services
  • Wihuri Group

Vendors' Activities In The Pharmaceutical Packaging Market Include:

  • Expansion activities are helping the vendors to improve their global distribution networks, allowing the players to explore untapped opportunities.
  • Large-scale investments and funding in the pharmaceutical packaging market are seen through varied conglomerates and investment firms.

A Diverse Range of Pharmaceutical Packaging Products Offered In The Industry

  • A surge in technological innovations in pharmaceutical packaging and several new product launches can be witnessed in the pharmaceutical packaging market. For instance, on October 27, 2021, Amcor launched its dual-chamber pouch for drug-device combination product packaging in Europe.
  • Global players are projected to increase their footprint in the pharmaceutical packaging market, especially in terms of features and price.
  • Companies with a strong footprint in the developed nations are strategically expanding their business in low- and middle-income countries (LMIC), which can be attributed to the growing aging population and chronic diseases in those countries.

KEY QUESTIONS ANSWERED

1. How big is the pharmaceutical packaging market?
2. What is the growth rate of the global pharmaceutical packaging market?
3. Who are the key players in the global pharmaceutical packaging market?
4. Which region will dominate the global pharmaceutical packaging market?
5. What are the factors driving the pharmaceutical packaging market?
Frequently Asked Questions about the Pharmaceutical Packaging Market

What is the estimated value of the Pharmaceutical Packaging Market?

The Pharmaceutical Packaging Market was estimated to be valued at $81 Billion in 2021.

What is the growth rate of the Pharmaceutical Packaging Market?

The growth rate of the Pharmaceutical Packaging Market is 4.6%, with an estimated value of $106.37 Billion by 2027.

What is the forecasted size of the Pharmaceutical Packaging Market?

The Pharmaceutical Packaging Market is estimated to be worth $106.37 Billion by 2027.

Who are the key companies in the Pharmaceutical Packaging Market?

Key companies in the Pharmaceutical Packaging Market include Amcor, Aptar Group, Berry Global, Gerresheimer, WestRock, ACG, Airnov, AVI Global Plast, BD and Bilcare.

Table of Contents

1 Research Methodology2 Research Objectives3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.1.3 Market Estimation Caveats
4.2 Base Year
4.3 Scope of the Study
4.3.1 Market Segmentation by Type
4.3.2 Market Segmentation by Material
4.3.3 Market Segmentation by End-user
4.3.4 Market Segmentation by Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Overview
8 Premium Insights
8.1 Market Scenario
9 Market Opportunities & Trends
9.1 Increase in Focus on Eco-Friendly Packaging
9.2 Implementation of Nanotechnology in Pharmaceutical Packaging
9.3 Advances in Packaging Materials
10 Market Growth Enablers
10.1 Rise in Demand for Pharmaceuticals
10.2 High Demand for Primary Pharmaceutical Packaging
10.3 Surge in Demand for Flexible Packaging
11 Market Restraints
11.1 Surge in Home Delivery of Pharmaceutical Products
11.2 Stringent Regulatory Standards
11.3 Volatility in Raw Material Prices
12 Market Landscape
12.1 Market Overview
12.2 Market Size & Forecast
12.2.1 Insight by Type
12.2.2 Insight by Material
12.2.3 Insight by End-user
12.2.4 Insight by Geography
12.3 Five Forces Analysis
12.3.1 Threat of New Entrants
12.3.2 Bargaining Power of Suppliers
12.3.3 Bargaining Power of Buyers
12.3.4 Threat of Substitutes
12.3.5 Competitive Rivalry
13 Type
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Primary
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.3.3 Blister Packs
13.3.4 Market Size & Forecast
13.3.5 Bottles
13.3.6 Market Size & Forecast
13.3.7 Vials
13.3.8 Market Size & Forecast
13.3.9 Ampoules
13.3.10 Market Size & Forecast
13.3.11 Others
13.3.12 Market Size & Forecast
13.3.13 Market by Geography
13.4 Secondary
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.4.3 Market by Geography
13.5 Tertiary
13.5.1 Market Overview
13.5.2 Market Size & Forecast
13.5.3 Market by Geography
14 Material
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Paper
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.3.3 Market by Geography
14.4 Glass
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.4.3 Market by Geography
14.5 Plastic
14.5.1 Market Overview
14.5.2 Market Size & Forecast
14.5.3 Market by Geography
14.6 Others
14.6.1 Market Overview
14.6.2 Market Size & Forecast
14.6.3 Market by Geography
15 End-user
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Pharmaceutical Companies
15.3.1 Market Overview
15.3.2 Market Size & Forecast
15.3.3 Market by Geography
15.4 Cmos/Cdmos
15.4.1 Market Overview
15.4.2 Market Size & Forecast
15.4.3 Market by Geography
15.5 Others
15.5.1 Market Overview
15.5.2 Market Size & Forecast
15.5.3 Market by Geography
16 Geography
16.1 Market Snapshot & Growth Engine
16.2 Geographic Overview
17 North America
17.1 Market Overview
17.2 Market Size & Forecast
17.3 North America: Type
17.4 North America: Material
17.5 North America: End-user
17.6 Key Countries
17.6.1 Us: Market Size & Forecast
17.6.2 Canada: Market Size & Forecast
18 Europe
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Europe: Type
18.4 Europe: Material
18.5 Europe: End-user
18.6 Key Countries
18.6.1 Germany: Market Size & Forecast
18.6.2 Uk: Market Size & Forecast
18.6.3 France: Market Size & Forecast
18.6.4 Italy: Market Size & Forecast
18.6.5 Spain: Market Size & Forecast
19 Apac
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Apac: Type
19.4 Apac: Material
19.5 Apac: End-user
19.6 Key Countries
19.6.1 China: Market Size & Forecast
19.6.2 Japan: Market Size & Forecast
19.6.3 South Korea: Market Size & Forecast
19.6.4 India: Market Size & Forecast
19.6.5 Australia: Market Size & Forecast
20 Latin America
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Latin America: Type
20.4 Latin America: Material
20.5 Latin America: End-user
20.6 Key Countries
20.6.1 Brazil: Market Size & Forecast
20.6.2 Mexico: Market Size & Forecast
20.6.3 Argentina: Market Size & Forecast
21 Middle East & Africa
21.1 Market Overview
21.2 Market Size & Forecast
21.3 Middle East & Africa: Type
21.4 Middle East & Africa: Material
21.5 Middle East & Africa: End-user
21.6 Key Countries
21.6.1 Turkey: Market Size & Forecast
21.6.2 Saudi Arabia: Market Size & Forecast
21.6.3 South Africa: Market Size & Forecast
22 Competitive Landscape
22.1 Competition Overview
22.2 Market Share Analysis
22.2.1 Amcor
22.2.2 Aptargroup
22.2.3 Berry Global
22.2.4 Gerresheimer
22.2.5 Westrock
23 Key Company Profiles
23.1 Amcor
23.1.1 Business Overview
23.1.2 Product Offerings
23.1.3 Key Strategies
23.1.4 Key Strengths
23.1.5 Key Opportunities
23.2 Aptargroup
23.2.1 Business Overview
23.2.2 Product Offerings
23.2.3 Key Strategies
23.2.4 Key Strengths
23.2.5 Key Opportunities
23.3 Berry Global
23.3.1 Business Overview
23.3.2 Product Offerings
23.3.3 Key Strategies
23.3.4 Key Strengths
23.3.5 Key Opportunities
23.4 Gerresheimer
23.4.1 Business Overview
23.4.2 Product Offerings
23.4.3 Key Strategies
23.4.4 Key Strengths
23.4.5 Key Opportunities
23.5 Westrock
23.5.1 Business Overview
23.5.2 Product Offerings
23.5.3 Key Strategies
23.5.4 Key Strengths
23.5.5 Key Opportunities
24 Other Prominent Vendors
24.1 Acg
24.1.1 Business Overview
24.1.2 Product Offerings
24.2 Airnov
24.2.1 Business Overview
24.2.2 Product Offerings
24.3 Avi Global Plast
24.3.1 Business Overview
24.3.2 Product Offerings
24.4 Bd
24.4.1 Business Overview
24.4.2 Product Offerings
24.5 Bilcare
24.5.1 Business Overview
24.5.2 Product Offerings
24.6 Borosil
24.6.1 Business Overview
24.6.2 Product Offerings
24.7 Ccl Industries
24.7.1 Business Overview
24.7.2 Product Offerings
24.8 Coesia
24.8.1 Business Overview
24.8.2 Product Offerings
24.9 Drug Plastics Group
24.9.1 Business Overview
24.9.2 Product Offerings
24.10 Dwk Life Sciences
24.10.1 Business Overview
24.10.2 Product Offerings
24.11 Log
24.11.1 Business Overview
24.11.2 Product Offerings
24.12 Meghmani Group
24.12.1 Business Overview
24.12.2 Product Offerings
24.13 Neelam Global
24.13.1 Business Overview
24.13.2 Product Offerings
24.14 Nolato
24.14.1 Business Overview
24.14.2 Product Offerings
24.15 Nemera
24.15.1 Business Overview
24.15.2 Product Offerings
24.16 Polycine
24.16.1 Business Overview
24.16.2 Product Offerings
24.17 Renolit
24.17.1 Business Overview
24.17.2 Product Offerings
24.18 Schur Flexibles Holding
24.18.1 Business Overview
24.18.2 Product Offerings
24.19 Specialty Polyfilms
24.19.1 Business Overview
24.19.2 Product Offerings
24.20 Sgd Pharma
24.20.1 Business Overview
24.20.2 Product Offerings
24.21 Schott
24.21.1 Business Overview
24.21.2 Product Offerings
24.22 Sippex Iv Bags
24.22.1 Business Overview
24.22.2 Product Offerings
24.23 Super Olefins
24.23.1 Business Overview
24.23.2 Product Offerings
24.24 West Pharmaceutical Services
24.24.1 Business Overview
24.24.2 Product Offerings
24.25 Wihuri Group
24.25.1 Business Overview
24.25.2 Product Offerings
25 Report Summary
25.1 Key Takeaways
25.2 Strategic Recommendations
26 Quantitative Summary
26.1 Market by Geography
26.2 Market by Type
26.3 Market by Type (Primary)
26.4 Market by Material
26.5 Market by End-user
26.6 North America by Type
26.7 North America by Type (Primary)
26.8 North America by Material
26.9 North America by End-user
26.10 Europe by Type
26.11 Europe by Type (Primary)
26.12 Europe by Material
26.13 Europe by End-user
26.14 APAC by Type
26.15 APAC by Type ( Primary)
26.16 APAC by Material
26.17 APAC by End-user
26.18 Latin America by Type
26.19 Latin America by Type (Primary)
26.20 Latin America by Material
26.21 Latin America by End-user
26.22 Middle East & Africa by Type
26.23 Middle East & Africa by Type (Primary)
26.24 Middle East & Africa by Material
26.25 Middle East & Africa by End-user
27 Appendix
27.1 Abbreviations

Companies Mentioned

  • Amcor
  • Aptar Group
  • Berry Global
  • Gerresheimer
  • WestRock
  • ACG
  • Airnov
  • AVI Global Plast
  • BD
  • Bilcare
  • Borosil
  • CCL Industries
  • Coesia
  • Drug Plastics Group
  • DWK Life Sciences
  • LOG
  • Meghmani Group
  • Neelam Global
  • Nolato
  • Nemera
  • PolyCine
  • RENOLIT
  • Schur Flexibles Holding
  • Specialty Polyfilms
  • SGD Pharma
  • SCHOTT
  • Sippex IV bags
  • SUPER OLEFINS
  • West Pharmaceutical Services
  • Wihuri Group

Methodology


Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.

Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.



 

Loading
LOADING...